Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:42 pm Purchase | 2023-12-31 | 13G | Pharvaris N.V. PHVS | Venrock Healthcare Capital Partners III L.P. | 3,395,606 6.500% | 912,000 (+36.72%) | Filing History |
| 2024-02-14 10:27 am Purchase | 2023-12-31 | 13G | Pharvaris N.V. PHVS | VIKING GLOBAL INVESTORS LP | 3,656,923 7.000% | 425,000 (+13.15%) | Filing History |
| 2024-02-13 2:14 pm Purchase | 2023-12-31 | 13G | Pharvaris N.V. PHVS | Foresite Capital Fund IV L.P. | 4,038,842 7.800% | 757,774 (+23.10%) | Filing History |
| 2024-02-13 10:12 am Purchase | 2023-12-31 | 13G | Pharvaris N.V. PHVS | GENERAL ATLANTIC L.P. | 7,531,252 14.100% | 3,125,000 (+70.92%) | Filing History |
| 2024-02-09 09:28 am Purchase | 2024-02-08 | 13G | Pharvaris N.V. PHVS | FMR LLC | 5,192,984 9.989% | 1,877,746 (+56.64%) | Filing History |
| 2024-02-08 4:16 pm Sale | 2023-12-31 | 13G | Pharvaris N.V. PHVS | LSP V Cooperatieve U.A. | 3,556,805 6.800% | -50,761 (-1.41%) | Filing History |
| 2024-01-24 6:41 pm Purchase | 2023-12-06 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III L.P. | 4,382,504 8.400% | 117,832 (+2.76%) | Filing History |
| 2024-01-22 4:30 pm Sale | 2024-01-18 | 13G | Pharvaris N.V. PHVS | Bain Capital Life Sciences Fund L.P. | 1,967,093 3.800% | -918,173 (-31.82%) | Filing History |
| 2023-11-30 4:15 pm Purchase | 2023-11-20 | 13G | Pharvaris N.V. PHVS | Venrock Healthcare Capital Partners III L.P. | 2,483,606 6.100% | 2,483,606 (New Position) | Filing History |
| 2023-06-23 4:34 pm Unchanged | 2023-06-21 | 13G | Pharvaris N.V. PHVS | Bain Capital Life Sciences Fund L.P. | 2,885,266 7.100% | 0 (Unchanged) | Filing History |
| 2023-06-23 3:07 pm Purchase | 2023-06-21 | 13G | Pharvaris N.V. PHVS | GENERAL ATLANTIC L.P. | 4,406,252 10.800% | 1,986,097 (+82.06%) | Filing History |
| 2023-06-21 4:33 pm Purchase | 2023-06-16 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III L.P. | 4,264,672 10.400% | 1,963,221 (+85.30%) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Pharvaris N.V. PHVS | VIKING GLOBAL INVESTORS LP | 3,231,923 9.700% | 776,387 (+31.62%) | Filing History |
| 2023-02-13 4:56 pm Sale | 2022-12-31 | 13G | Pharvaris N.V. PHVS | Foresite Capital Fund IV L.P. | 3,281,068 9.700% | -15,000 (-0.46%) | Filing History |
| 2023-02-09 12:01 pm Purchase | 2023-02-09 | 13G | Pharvaris N.V. PHVS | FMR LLC | 3,315,238 9.999% | 20,129 (+0.61%) | Filing History |
| 2022-09-26 4:24 pm Sale | 2021-02-09 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III L.P. | 2,301,451 6.900% | -1,859 (-0.08%) | Filing History |
| 2022-02-14 5:01 pm Purchase | 2021-12-31 | 13G | Pharvaris N.V. PHVS | VIKING GLOBAL INVESTORS LP | 2,455,536 7.400% | 35,381 (+1.46%) | Filing History |
| 2022-02-11 3:12 pm Sale | 2021-12-31 | 13G | Pharvaris N.V. PHVS | Foresite Capital Fund IV L.P. | 3,296,068 9.900% | -630,000 (-16.05%) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Pharvaris N.V. PHVS | FMR LLC | 3,295,109 9.946% | 3,295,109 (New Position) | Filing History |
| 2022-02-03 4:18 pm Purchase | 2021-12-31 | 13G | Pharvaris N.V. PHVS | LSP V Cooperatieve U.A. | 3,607,566 10.900% | 3,607,566 (New Position) | Filing History |